We are part of Cencora.
Cencora brings AmerisourceBergen and all of our companies and services together under one new name. While we are expanding our network of like-minded pharmacists, physicians, caregivers and healthcare continuum, our commitment to supporting your ability to provide patient-centric care has never been more of a focus. It’s business as usual while our full transition unfolds over time.
Supporting specialty practices along the journey to excellence
Greater access and choice for specialty practices powered by our legacy GPO
June 14-15, 2024 | Omni PGA Frisco | Frisco, TX
SPN Vision Exchange
*For Vision practice members
Join us for our live SPN Vision Exchange event taking place in June at the Omni PGA in Frisco, TX. This live meeting is for our Vision Practice Network and gives GPO members the opportunity to interact face-to-face with peers and industry leaders.
Agenda highlights include:
- Coding, Billing and Reimbursement Updates | Elizabeth Cifers
- Anti-VEGF Therapies for Wet AMD, DME and RVO | John Kitchens, MD
- Geographic Atrophy: Clinical and Administrative Approach | John Kitchens, MD and Jeff Brockette, MSHA
- Updates in IRD and CGT | Ramiro S. Maldonado, MD
- Biosimilars in Retina | David Brown, MD, FACS
- Anti-inflammatories in the Treatment of Uveitis, DME and RVO | Mark Dacey, MD
- Retina Imaging and New Technologies | Mark Barakat, MD
If you would like join us in Texas, register today to reserve your spot at SPN Vision Exchange 2024.
Reach out to SPNvisionexchange24@travelhq.com with any questions.
Global Provider Insights Network® (GPIN)
Participate in honoraria-based market research
Begin by completing a short questionnaire, which marks your first step in sharing insights that contribute to the progression of patient care. For your valuable input and time, you will receive an honorarium based on fair market value.
OnCall podcast
Biosimilar Basics: Market Landscape
In this episode, the second of our Biosimilars series, Brian Biehn, Senior Director of Biosimilar Injectables, and Connor Nell, Director of Commercialization Injectables discuss the current Biosimilar landscape and what we can expect to see in the market.
Our next episode will feature information on biosimilar legislation. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCallGPO@gmail.com.
Technology and insights to elevate your practice
We help you focus on what matters most — patient care
Medically Integrated Dispensing
Optimize access and purchasing power
MIPS Consulting Services
Navigate industry changes
Your Smart GPO
What does it mean to be a Smart GPO? For us, it means using data and actionable insights to support your practice in the transition to value-based care. It means providing analytics tools to help you align with national guidelines. And it means using empirical evidence to put patient outcomes at the heart of your practice's health and sustainability.
When you join our Smart GPO, you become part of a network of specialty practices making data-backed decisions to advance the quality of patient care. That's having a smart partner in your corner.
